Contact Us

Newest

Mr. Lee Tongge, a Chinese Traditional Culture Master from SEER ONNET PTE.LTD., was invited to attend the LC Lucky Year Salon of the AIA Macau Founding Team

02-17

Mr. Lee Tongge, a Chinese Traditional Culture Master from SEER ONNET PTE.LTD., was invited to attend the LC Lucky Year Salon of the AIA Macau Founding Team

Woolpert Welcomes Head of Strategic Growth, Asia-Pacific Susie Henderson

02-14

Woolpert Welcomes Head of Strategic Growth, Asia-Pacific Susie Henderson

Aker Horizons ASA: Fourth-quarter results 2024

02-14

Aker Horizons ASA: Fourth-quarter results 2024

Cloud4C Secures Dual AI Specializations on Microsoft Azure, Strengthening AI Capabilities

02-14

Cloud4C Secures Dual AI Specializations on Microsoft Azure, Strengthening AI Capabilities

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

02-14

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

Polyplastics Launches New Eco-friendly PLASTRON (R) ︎LFT with Reduced Weight, Higher Rigidity, and Strong Damping

02-14

Polyplastics Launches New Eco-friendly PLASTRON (R) ︎LFT with Reduced Weight, Higher Rigidity, and Strong Damping

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

02-14

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

Fujitsu to offer Fujitsu Cloud Service Generative AI Platform for secure and flexible enterprise data management

02-14

Fujitsu to offer Fujitsu Cloud Service Generative AI Platform for secure and flexible enterprise data management

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

02-14

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

CRIMSONLOGIC AND BDO SINGAPORE SIGN STRATEGIC PARTNERSHIP TO DEVELOP SPECIALIZED GENERATIVE AI ADVISORY PLATFORM

02-14

CRIMSONLOGIC AND BDO SINGAPORE SIGN STRATEGIC PARTNERSHIP TO DEVELOP SPECIALIZED GENERATIVE AI ADVISORY PLATFORM

©copyright2009-2020 Detroit Tech Daily    Contact Us SiteMap